CAD 0.07
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 449.74 Thousand CAD | -66.99% |
2022 | 1.36 Million CAD | -58.02% |
2021 | 3.24 Million CAD | 667.53% |
2020 | 422.92 Thousand CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | -100.0% |
2017 | 2462.00 CAD | 0.0% |
2016 | - CAD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 418.71 Thousand CAD | -3.63% |
2024 Q1 | 434.48 Thousand CAD | -3.39% |
2024 Q3 | 402.39 Thousand CAD | -3.9% |
2023 Q4 | 449.74 Thousand CAD | -10.85% |
2023 Q3 | 504.49 Thousand CAD | -12.22% |
2023 FY | 449.74 Thousand CAD | -66.99% |
2023 Q1 | 1.3 Million CAD | -3.87% |
2023 Q2 | 574.71 Thousand CAD | -56.12% |
2022 FY | 1.36 Million CAD | -58.02% |
2022 Q3 | 1.35 Million CAD | -5.95% |
2022 Q2 | 1.43 Million CAD | -21.99% |
2022 Q1 | 1.84 Million CAD | -43.22% |
2022 Q4 | 1.36 Million CAD | 0.76% |
2021 Q4 | 3.24 Million CAD | 5.99% |
2021 Q3 | 3.06 Million CAD | 9.03% |
2021 Q2 | 2.8 Million CAD | 579.46% |
2021 FY | 3.24 Million CAD | 667.53% |
2021 Q1 | 413.4 Thousand CAD | -2.25% |
2020 Q3 | 207.32 Thousand CAD | 15.87% |
2020 FY | 422.92 Thousand CAD | 0.0% |
2020 Q4 | 422.92 Thousand CAD | 103.99% |
2020 Q2 | 178.92 Thousand CAD | -5.95% |
2020 Q1 | 190.24 Thousand CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2018 Q1 | - CAD | -100.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 FY | - CAD | -100.0% |
2017 Q3 | - CAD | 0.0% |
2017 FY | 2462.00 CAD | 0.0% |
2017 Q4 | 2462.00 CAD | 0.0% |
2016 FY | - CAD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Aion Therapeutic Inc. | 826.47 Thousand CAD | 45.582% |
Ayurcann Holdings Corp. | 709.07 Thousand CAD | 36.573% |
Blueberries Medical Corp. | 12.8 Thousand CAD | -3412.543% |
The BC Bud Corporation | 229.35 Thousand CAD | -96.092% |
BioNxt Solutions Inc. | 4.89 Million CAD | 90.811% |
CordovaCann Corp. | 6.37 Million CAD | 92.95% |
Christina Lake Cannabis Corp. | 6.09 Million CAD | 92.622% |
Captor Capital Corp. | 6.71 Million CAD | 93.302% |
City View Green Holdings Inc. | 1.49 Million CAD | 69.988% |
1CM Inc. | 6.39 Million CAD | 92.966% |
Global Hemp Group Inc. | 3.55 Million CAD | 87.355% |
Greenway Greenhouse Cannabis Corporation | 16.02 Million CAD | 97.193% |
IM Cannabis Corp. | 13.78 Million CAD | 96.737% |
Lobe Sciences Ltd. | 332.64 Thousand CAD | -35.205% |
Maple Leaf Green World Inc. | 2.47 Million CAD | 81.83% |
Mountain Valley MD Holdings Inc. | - CAD | -Infinity% |
Ovation Science Inc. | 192.61 Thousand CAD | -133.495% |
Pharmadrug Inc. | 1.76 Million CAD | 74.545% |
Captiva Verde Wellness Corp. | 191.7 Thousand CAD | -134.604% |
RAMM Pharma Corp. | 405.14 Thousand CAD | -11.01% |
RIV Capital Inc. | 6.59 Million CAD | 93.178% |
Revive Therapeutics Ltd. | 25.21 Thousand CAD | -1683.574% |
Red White & Bloom Brands Inc. | 262.13 Million CAD | 99.828% |
SLANG Worldwide Inc. | 29.86 Million CAD | 98.494% |
1933 Industries Inc. | 17.57 Million CAD | 97.44% |
Red Light Holland Corp. | 811.04 Thousand CAD | 44.547% |
Top Strike Resources Corp. | 13.29 Million CAD | 96.616% |
Xebra Brands Ltd. | - CAD | -Infinity% |
Adastra Holdings Ltd. | 3.58 Million CAD | 87.449% |